Key facts
- This page summarizes Mark Leonard Singleton's Form 4 filing for Bioventus Inc. (BVS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Mar 2023, 16:15.
Mark Leonard Singleton - 21 Mar 2023 Form 4 Insider Report for Bioventus Inc. (BVS)
- Reporting relationship
- SVP & CFO
- Issuer ticker
- BVS
- Reported as of
- 21 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Mar 2023, 16:15:33 UTC
- Prior SEC filing
- 05 Apr 2022
- Next SEC filing
- 27 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Anthony D'Adamio, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark Leonard Singleton filed Form 4 for Bioventus Inc. (BVS) on 23 Mar 2023.
Change
- Previous filing in this sequence was filed on 05 Apr 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BVS
transaction
Class A Common Stock
Options Exercise
- Transaction value
- Shares
- +18,625
- Change %
- Price
- Shares after
- 18,625
- Date
- 21 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BVS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -18,625
- Change %
- -25%
- Price
- $0.000000
- Shares after
- 55,875
- Date
- 21 Mar 2023
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 18,625
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
Footnote F2
The original grant of 74,500 RSUs vests in four approximately equal annual installments that began on March 21, 2023.